Physician

Joy Tang, MD

According to 2025 Medicare claims, Joy Tang, MD (NPI: 1679006019) practices hematology/oncology in the Columbus, OH market, with the plurality of this provider's patient population coming from Franklin, OH. This provider's primary affiliated billing organization is COLUMBUS ONCOLOGY ASSOCIATES INC (NPI: 1790875656; TIN: 311211874) and primary practice location at 43082-7989.

Tang's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 235 traditional Medicare patients, billed 36,078 HCPCS/CPT codes, and received $523,061 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 525 prescription claims across 107 beneficiaries totaling $1,675,505 in drug costs, led by Imbruvica (Ibrutinib). No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $967 to $1,675,505. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$262K$523K2023 Medicare payment: $90,059 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $523,061 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
2023706,365$90,059
202423536,078$523,061

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$838K$1.7M2018 Drug cost: $967 (USD; Tot_Drug_Cst)2019 Drug cost: $642 (USD; Tot_Drug_Cst)2020 Drug cost: $855 (USD; Tot_Drug_Cst)2021 Drug cost: $6,036 (USD; Tot_Drug_Cst)2022 Drug cost: $3,640 (USD; Tot_Drug_Cst)2023 Drug cost: $155,688 (USD; Tot_Drug_Cst)2024 Drug cost: $1,675,505 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/R12$967
2019N/R14$642
2020N/R17$855
20212838$6,036
20222449$3,640
20232444$155,688
2024107525$1,675,505

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99204New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more3838$125
99222Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes4243$99
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more59130$92
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more3448$53
G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's66155$12

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
ImbruvicaIbrutinib26728$454,724
FotivdaTivozanib Hcl12336$372,428
AnastrozoleAnastrozole1155,749$1,340
Tamoxifen CitrateTamoxifen Citrate271,369$490
Potassium ChloridePotassium Chloride30455$410

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

FAQ

What Medicare data is available for Joy Tang, MD?

Tedicare shows public-source Medicare data for Joy Tang, MD (NPI 1679006019), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Joy Tang, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Joy Tang, MD?

Joy Tang, MD is linked to COLUMBUS ONCOLOGY ASSOCIATES INC (billing NPI 1790875656) in the available physician profile data.

Does Joy Tang, MD have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.